title: Continuous infusion of apomorphine in patients with advanced Parkinson's disease and different degrees of functional disability.
authors.affiliation: Servicio de Neurología, Hospital Consorci Sanitari de Terrassa, Barcelona, España. Electronic address: gsalaz64@gmail.com.
authors.forename: G
authors.initials: G
authors.lastname: Salazar
authors.affiliation: Servicio de Neurología, Hospital Consorci Sanitari de Terrassa, Barcelona, España.
authors.forename: J
authors.initials: J
authors.lastname: Martín
authors.affiliation: Servicio de Neurología, Hospital Consorci Sanitari de Terrassa, Barcelona, España.
authors.forename: M
authors.initials: M
authors.lastname: Fragoso
authors.affiliation: Servicio de Neurología, Hospital Consorci Sanitari de Terrassa, Barcelona, España.
authors.forename: M A
authors.initials: MA
authors.lastname: Font
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000978:Antiparkinson Agents / Q000008:administration & dosage; D001058:Apomorphine / Q000008:administration & dosage* / Q000009:adverse effects; D018491:Dopamine Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D055104:Infusions, Subcutaneous; D007980:Levodopa / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007980:Levodopa; D001058:Apomorphine